Abstract
This Letter describes the synthesis and SAR of the novel positive allosteric modulator, VU0155041, a compound that has shown in vivo efficacy in rodent models of Parkinson's disease. The synthesis takes advantage of an iterative parallel synthesis approach to rapidly synthesize and evaluate a number of analogs of VU0155041.
Original language | English |
---|---|
Journal | Bioorganic & Medicinal Chemistry Letters |
Volume | 19 |
Issue number | 17 |
Pages (from-to) | 4967-70 |
Number of pages | 4 |
ISSN | 0960-894X |
DOIs | |
Publication status | Published - 1 Sept 2009 |
Externally published | Yes |
Keywords
- Allosteric Regulation/drug effects
- Allosteric Site
- Anilides/chemical synthesis
- Animals
- Cyclohexanecarboxylic Acids/chemical synthesis
- Disease Models, Animal
- Parkinson Disease/drug therapy
- Rats
- Receptors, Metabotropic Glutamate/chemistry
- Structure-Activity Relationship